The Role of Pro-angiogenic Immune Cells in Human Pregnancies

• Conditions: Fetal Growth Retardation; Preeclampsia
• Interventions: Other: Biological specimen

• Registration Number: NCT01177020
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

Identification of the presence of proangiogenic immune cells in normal human placentas may enable predication of some pregnancy disorders.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-05-12
• Status Verified: 2010-08
• Study Start: 2010-08
• Study First Submitted QC: 2010-08-05
• Last Update Submitted: 2010-08-05
• Study First Posted: 2010-08-06
• Last Update Posted: 2010-08-06
• Primary Completion: 2011-08
• Study Completion: 2011-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

• Placentas that have been delivered in the Medical Center

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Placentas after delivery or abortion	Biological specimen	-

Primary Outcome Measures

Name	Time	Method
To find the angiogenic potential of proangiogenic immune cells derived from human placentas.	Two years

Trial Locations

Locations (1)

Hillel Yaffe Medical Center; 🇮🇱 Hadera, Israel